Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

Current therapies for advanced hepatocellular carcinoma (HCC) are marginally effective and exacerbate underlying liver disease. The ability of immunotherapy to elicit nontoxic, systemic, long-lived anti-tumor activity makes it particularly well-suited for use in the setting of HCC. While therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardee, Angela D., Butterfield, Lisa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376967/
https://www.ncbi.nlm.nih.gov/pubmed/22720211
http://dx.doi.org/10.4161/onci.1.1.18344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376967/
https://www.ncbi.nlm.nih.gov/pubmed/22720211
http://dx.doi.org/10.4161/onci.1.1.18344

Ejemplares similares